Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase

Thrombosis and Haemostasis

Volumn 90, Issue 1, 2003, Pages 64-70

  Leach, J Kent ^a,b   O'Rear, Edgar A ^a,b   Patterson, Eugene ^c   Miao, Yiwei ^d   Johnson, Arthur E ^d  

^a University of Oklahoma   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Liposomes; Microencapsulation; Streptokinase; Thrombolytic therapy; Thrombus

Indexed keywords

DIOLEOYLPHOSPHATIDYLCHOLINE; LIPOSOME; MACROGOL; OCTYL GLUCOSIDE; POLYMER; STREPTOKINASE; THROMBIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; CAROTID ARTERY FLOW; CAROTID ARTERY THROMBOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENTIATION; DRUG STORAGE; ENCAPSULATION; FEMALE; FIBRINOLYTIC THERAPY; JUGULAR VEIN; MALE; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION; THROMBOGENESIS;

EID: 0037961999     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613600     Document Type: Article

References (28)

1. American Heart Association. Heart Disease and Stroke Statistics - 2003 Update. Dallas, Texas: American Heart Association, 2002.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
3. The Multicenter Acute Stroke Trial - Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 1996; 335: 145-50.
4. Francis CW, Marder VJ. Mechanisms of fibrinolysis. In: Hematology. Williams, Beutler, Erslev, Lichtman, eds: McGraw-Hill 1983; 1266-76.
5. Juhlin P, Bostrom PA, Torp A, et al. Streptokinase antibodies inhibit reperfusion during thrombolytic therapy with streptokinase in acute myocardial infarction. J Intern Med 1999; 245: 483-8.
6. Tuliani VV, O'Rear EA. Circulatory concentrations of fibrinolytic species during thrombolytic therapy estimated by stirred-tank reactor analysis. Pharm Res 1997; 14: 1051-7.
7. Nguyen PD, O'Rear EA, Johnson AE, et al. Thrombolysis using liposomal-encapsulated streptokinase: An in vitro study. Proc Soc Expt Biol Med 1989; 192: 261-9.
8. Nguyen PD, O'Rear EA, Johnson AE, et al. Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase. Circ Res 1990; 66: 875-8.
9. Li ZL, Zhang NZ, Nie YH. Accelerated thrombolysis by liposomal-encapsulated urokinase in a canine model of acute myocardial infarction. Chung Hua I Hsueh Tsa Chih 1994; 74: 338-40.
10. Heeremans JLM, Prevost R, Bekkers MEA, et al. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: A comparison with free t-PA. Thromb Haemost 1995; 73: 488-94.
11. Perkins WR, Vaughan DE, Plavin SR, et al. Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model. Thromb Haemost 1997; 77: 1174-8.
12. Watts PJ, Davies MC, Mella CD. Microencapsulation using emulsification/solvent evaporation: An overview of techniques and applications. Crit Rev Ther Drug Carrier Syst 1990; 3: 235-59.
13. Harris JM. Introduction to biotechnical and biomedical applications of poly(ethylene glycol). In: Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications. Harris, ed: Plenum Press 1992; 1-14.
14. Jameela SR, Misra A, Jayakrishnan A. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J Biomater Sci Polym Ed 1994; 6: 621-32.
15. Jayakrishnan A, Jameela SR. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. Biomaterials 1996; 17: 471-84.
16. Oner L, Groves MJ. Properties of human albumin microparticles prepared by a chilled cross-linking technique. J Pharm Pharmacol 1993; 45: 866-70.
17. Jackson KW, Esmon N, Tang J. Streptokinase and staphylokinase. Methods Enzymol 1981; 80: 387-94.
18. Jeynes BJ. Treatment of experimentally induced cerebral atherothromboembolism in an animal model with streptokinase and taurochenodeoxycholate. Artery 1988; 15: 259-71.
19. Haglund AC, Ronquist G, Frithz G, et al. Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatment. Thromb Res 2000; 98: 147-56.
20. Collen D. Thrombolytic therapy. Thromb Haemost 1997; 78: 742-6.
21. Reimer KA, Lowe JE, Rasmussen MM, et al. The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 1977; 56: 786-94.
22. Liem AL, Van't Hof AWJ, Hoorntje JCA, et al. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1998; 32: 629-33.
23. Heeremans JLM, Prevost R, Feltsma H, et al. Clot accumulation characteristics of plasminogen-bearing liposomes in a flow-system. Thromb Haemost 1998; 79: 144-9.
24. Juliano RL. Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres, and emulsions. Adv Drug Deliv Rev 1988; 2: 31-54.
25. Semple SC, Chonn A, Cullis PR. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv Drug Deliv Rev 1998; 32: 3-17.
26. Zalipsky S, Lee C. Use of functionalized poly(ethylene glycol)s for modification of polypeptides. In: Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications. Harris, ed: Plenum Press 1992; 347-370.
27. Heeremans JLM, Gerritsen HR, Meusen SP, et al. The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: Entrapment efficiency and ultracentrifugation damage. J Drug Target 1995; 3: 301-10.
28. Heeremans JLM, Mijnheer FW, Gerritsen HR, et al. Long-term stability of liposomes containing both tissue-type plasminogen activator and glu-plasminogen. Int J Pharm 1996; 129: 191-202.